If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.60    0.02 (0.74%)
Bid:
2.60
Ask:
2.82
Spread: 0.22 (8.462%)
Market Cap: £4.74m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Director/PDMR Shareholding

1 Nov 2019 07:00

RNS Number : 9023R
Nanoco Group PLC
01 November 2019
 

1 November 2019

NANOCO GROUP PLC

("Nanoco", the "Company" or the "Group")

 

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY

 

Nanoco (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, announces that on 31 October 2019, nil-cost options over ordinary shares of 10 pence each in the Company ("Ordinary Shares") were granted under the Nanoco 2015 Deferred Bonus Plan to the executive directors below:

 

Executive Director

Role

Number of Options granted over Ordinary Shares

Michael Edelman

CEO

731,151

Brian Tenner

COO & CFO

521,634

Nigel Pickett

CTO

437,681

 

Ordinarily, the options will vest following the announcement of Nanoco's results for its financial year ending 31 July 2021.

As set out in the Company's 2019 Annual Report, the award above represents 50% of the annual bonus earned by each executive director in the financial year ending 31 July 2019. The balance of the annual bonus would ordinarily be payable in cash, in line with the current shareholder approved remuneration policy which states that at least 50% of any annual bonus should be paid in cash.

The Board is currently seeking shareholder approval for a resolution at the AGM on 5 December 2019 to amend this rule to allow up to 100% of any annual bonus earned to be paid in Deferred Bonus Plan share awards rather than cash as the Board considers this to be in the best interests of the Company at the current time. In the event that the resolution is approved, a further identical award to the one described in this announcement would be made shortly thereafter. For the avoidance of doubt, the proposed policy amendment has no impact on the actual amount or maximum amount of bonus that has been or could be earned.

This notification is made pursuant to Disclosure and Transparency Rule 3.1.4. The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

For further information, please contact:

Nanoco Group PLC

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

Brian Tenner, Chief Financial Officer

Caroline Watson, Investor Relations Manager

Tel: + 44 (0) 7799 897357

cwatson@nanocotechnologies.com

 

MHP Communications

Tel: +44 (0) 20 3128 8570

Reg Hoare / Giles Robinson / Pete Lambie

nanoco@mhpc.com

 

 

Notification of Dealing Form

1.

Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

MICHAEL EDELMAN

2.

Reason for the notification

a)

Position /status

CHIEF EXECUTIVE OFFICER

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

NANOCO GROUP PLC

b)

LEI code

213800HOSJEZO1KOCV33

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Type of instrument:Identification code

OPTIONS OVER ORDINARY SHARES OF 1O PENCE EACH

ISIN: GB00B01JLR99

b)

Nature of the transaction

GRANT OF DEFERRED BONUS PLAN OPTIONS OVER ORDINARY SHARES UNDER THE NANOCO 2015 DEFERRED BONUS PLAN

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

731,151

d)

Aggregated information:- Aggregated volume- Price

N/A

e)

Date of the transaction

31 OCTOBER 2019

f)

Place of the transaction

OUTSIDE A TRADING VENUE

Notification of Dealing Form

1.

Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

DR NIGEL PICKETT

2.

Reason for the notification

a)

Position /status

CHIEF TECHNICAL OFFICER

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

NANOCO GROUP PLC

b)

LEI code

213800HOSJEZO1KOCV33

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Type of instrument:Identification code

OPTIONS OVER ORDINARY SHARES OF 1O PENCE EACH

ISIN: GB00B01JLR99

b)

Nature of the transaction

GRANT OF DEFERRED BONUS PLAN OPTIONS OVER ORDINARY SHARES UNDER THE NANOCO 2015 DEFERRED BONUS PLAN

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

437,681

d)

Aggregated information:- Aggregated volume- Price

N/A

e)

Date of the transaction

31 OCTOBER 2019

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

 

Notification of Dealing Form

1.

Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

BRIAN TENNER

2.

Reason for the notification

a)

Position /status

CHIEF OPERATING OFFICER & CHIEF FINANCIAL OFFICER

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

NANOCO GROUP PLC

b)

LEI code

213800HOSJEZO1KOCV33

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Type of instrument:Identification code

OPTIONS OVER ORDINARY SHARES OF 1O PENCE EACH

ISIN: GB00B01JLR99

b)

Nature of the transaction

GRANT OF DEFERRED BONUS PLAN OPTIONS OVER ORDINARY SHARES UNDER THE NANOCO 2015 DEFERRED BONUS PLAN

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

521,634

d)

Aggregated information:- Aggregated volume- Price

N/A

e)

Date of the transaction

31 OCTOBER 2019

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKDDPNBDBKKN
Date   Source Headline
1st Jul 202610:24 amRNSPDMR Shareholding and Deferred Bonus Options
26th Jun 20267:00 amRNSCommencement of Shareholder Consultation
25th Jun 20267:00 amRNSBoard Update
19th Jun 202610:33 amRNSAdjournment of General Meeting
18th Jun 20267:00 amRNSIntention to adjourn General Meeting
9th Jun 20267:00 amRNSGlass Lewis recommendation
5th Jun 202611:55 amRNSTR-1: Notification of major holdings
27th May 20267:00 amRNSIntention to delist from London Stock Exchange
20th Apr 20265:37 pmRNSDirector/PDMR Shareholding
20th Apr 20267:00 amRNSInterim Results
13th Apr 20267:00 amRNSNotice of Results
26th Mar 20267:00 amRNSShoei Litigation Conclusion
19th Mar 20267:00 amRNSStay of Shoei Litigation
23rd Feb 20267:00 amRNSShoei Litigation Update
26th Jan 20267:00 amRNSConclusion of CDX process & Directorate changes
15th Jan 20261:08 pmRNSReceipt of Litigation Proceeds
13th Jan 20264:50 pmRNSResult of AGM
12th Jan 20267:00 amRNSLitigation update
9th Dec 20257:00 amRNSBlocklisting Six-Monthly Return
8th Dec 202511:16 amRNSNotice of AGM
27th Nov 20257:00 amRNSResponse to non-infringement claim
26th Nov 20257:00 amRNSAnnual Report and Accounts
20th Nov 20257:00 amRNSLitigation outcome – Settlement agreed
18th Nov 20257:07 amRNSPreliminary Results
13th Nov 20257:00 amRNSNotice of Results
4th Nov 20257:06 amRNSExtension of Joint Development Agreement
15th Oct 20257:00 amRNS-RAwarding of Government Grant
30th Sep 20254:30 pmRNSTotal Voting Rights and Share Capital
8th Sep 20257:00 amRNSIssue of Equity and Director/PDMR Shareholdings
19th Aug 20257:00 amRNSFull Year Trading Update & Director Retirement
9th Jun 20257:00 amRNSBLOCKLISTING SIX-MONTHLY RETURN
28th Apr 202510:48 amRNSJoint Development Agreement
25th Apr 20257:00 amRNSPatent infringement lawsuit against LG
17th Apr 20253:54 pmRNSHigh Court Confirmation of Capital Reduction
15th Apr 20257:00 amRNSInterim Results & Investor Presentation
13th Mar 20257:00 amRNSNotice of Results
21st Jan 20252:20 pmRNSAnnual General Meeting – Voting Results
18th Dec 20248:26 amRNSDirector/PDMR Shareholding
13th Dec 20241:23 pmRNSResult of General Meeting
9th Dec 20247:00 amRNSBlock Listing Six Monthly Return
6th Dec 20246:30 pmRNSNotice of AGM
29th Nov 20247:00 amRNSGlass Lewis and ISS recommendations
28th Nov 20243:23 pmRNSDirector/PDMR Shareholding
28th Nov 20241:25 pmRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNS2024 Annual Report
20th Nov 20247:00 amRNSPreliminary Results
15th Nov 202411:00 amRNSPosting of Circular and Notice of General Meeting
30th Oct 20247:01 amRNSCompletion of Buyback Programme
30th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.